Enhancing Patients lives

Ornovi is an early stage biotechnology company focused on changing the treatment paradigm for patients suffering from inflammatory/immunology disorders.

Technology

Next Generation Highly Selective JAK Inhibitors

Ornovi’s lead program has a unique differentiating profile with the potential to provide safer solution to patients, suffering from various inflammatory/immunology disorders. 

Learn More